The Importance of Concurrent Chemotherapy for T1 Esophageal Cancer: Role of FDG-PET/CT for Local Control

Ogino, Ichiro; Watanabe, Shun-ichi; Hirasawa, Kingo; Misumi, Toshihoro; Hata, Masaharu; Kunisaki, Chikara

doi:10.21873/invivo.11376

Cited by 2 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Non-contrast, low-dose CT scan from the skull vertex to the mid-thigh was conducted for attenuation correction and anatomical localization. All 18 F-FDG PET/CT images were visually interpreted by an experienced nuclear medicine physicians, and an SUV max value ≧3.5 was highly considered as a positive PET/CT result [36,37].…”

Section: Protocol For 18 F-fdg Pet/ct Scanmentioning

confidence: 99%

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis

Hsiao

Hsu

et al. 2020

BMC Cancer

View full text Add to dashboard Cite

Background: Second primary cancer of the esophagus is frequent in head and neck patients, especially in high-risk populations, and has a great impact on the prognosis. Although Positron emission tomography (PET)/computed tomography (CT) scan is commonly conducted in head and neck patients, its ability to detect early esophageal cancer is limited. Narrow-band imaging endoscopy is an accurate and convenient technique for esophageal examination. We aimed to compare PET/CT scan and narrow-band imaging endoscopy for the detection of esophageal cancer in head and neck cancer patients. Methods: From November 2015 to November 2018, all head and neck cancer patients who underwent both PET/CT scan and narrow-band imaging endoscopy at Changhua Christian Hospital were retrospectively enrolled. Descriptive statistics, receiver operating characteristic curve analysis, logistic regression analysis, independent Student's t-test, and Kaplan-Meier survival analysis were conducted with MedCalc Statistical Software. Results: A total of 147 subjects were included in the analysis; suspicious esophageal lesions were identified by PET/CT scan in 8 (5.44%) and by narrow-band imaging in 35 (23.81%). The final pathologic diagnoses were esophageal squamous cell carcinoma in 10 and high-grade dysplasia in 5. The respective sensitivity, specificity, and area under the curve for detecting suspicious esophageal lesions were 33.33, 97.73%, and 0.655 for PET/CT scan, and 100.0, 84.85%, and 0.924 for narrow-band imaging endoscopy. Hypopharyngeal or laryngeal location of the primary head and neck cancer was the only risk factor for developing second primary esophageal cancer. Conclusions: PET/CT scan was inferior to narrow-band imaging endoscopy in detecting second primary esophageal cancer in head and neck cancer patients. In addition to PET/CT scan, narrow-band imaging endoscopy should be considered in head and neck patients at high risk for developing second primary esophageal cancer.

show abstract

Section: Protocol For 18 F-fdg Pet/ct Scanmentioning

confidence: 99%

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis

Hsiao

Hsu

et al. 2020

BMC Cancer

View full text Add to dashboard Cite

show abstract

Użyteczność i ograniczenia badania 18F-FDG PET/CT w diagnostyce nowotworu złośliwego przełyku

Pietrzak¹,

Martenka

Strzesak

et al. 2020

LOS

View full text Add to dashboard Cite

Mimo ograniczeń techniki pozytonowej tomografii emisyjnej/tomografii komputerowej z użyciem radiofarmaceutyku 18F-Fluorodeoksyglukozy (18F-FDG PET/CT), wśród których wyróżniamy m.in. nieswoisty charakter radiofarmaceutyku 18F-FDG oraz niewielką dostępność, czy w końcu - wysokie koszty badania, liczni autorzy wskazują badanie 18F-FDG PET/CT jako najbardziej użyteczną metodę w procesie wykrywania, oceny stopnia zaawansowania i planowania leczenia nowotworu złośliwego przełyku.

show abstract

The Importance of Concurrent Chemotherapy for T1 Esophageal Cancer: Role of FDG-PET/CT for Local Control

Abstract: It is important to note that all patients with FDG-avid primary tumor in the no-CRT group developed local recurrence. This would suggest that concurrent chemotherapy is an integral part of disease management in patients with T1 esophageal squamous cell carcinoma.

Cited by 2 publications

References 21 publications

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis

Użyteczność i ograniczenia badania 18F-FDG PET/CT w diagnostyce nowotworu złośliwego przełyku

Contact Info

Product

Resources

About